Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach

22 Jun 2020

Abstract excerpt

2019 – Novel Coronavirus (2019-nCOV), enclosed large genome positive-sense RNA virus characterized by crown-like spikes that protrude from their surface, and have a distinctive replication strategy. The 2019-nCOV belongs to the Coronaviridae family, principally consists of virulent pathogens showing zoonotic property, has emerged as a pandemic outbreak with high mortality and high morbidity rate around the globe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32568620
DOI: 10.1080/07391102.2020.1781694

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approachPMID 32568620Read ↗

Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicinesSemantic proximity Read ↗

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screeningSemantic proximity Read ↗

Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoVSemantic proximity Read ↗

Investigating Potential Inhibitory Effect of <em>Uncaria tomentosa</em> (Cat's claw) against the Main Protease 3CL<sup>Pro</sup> of SARS-CoV-2 by Molecular ModelingSemantic proximity Read ↗

Identification of Potential Antiviral Lead Inhibitors Against Sars-Cov-2 Main Protease: Structure-Guided Virtual Screening, Docking, Adme, and Md Simulation Based ApproachSemantic proximity Read ↗

Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332Semantic proximity Read ↗

Repurposing Remdesivir for COVID-19: Computational Drug Design Targeting SARS-CoV-2 RNA Polymerase and Main Protease using Molecular Dynamics ApproachSemantic proximity Read ↗

ABBV-744 and Onalespid as Potential Inhibitors of SARS-CoV-2 main Protease Enzyme: A Promising Therapeutics in COVID-19?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.